Does IMATINIB Cause Pulmonary hypertension? 107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Pulmonary hypertension have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.
107
Reports of Pulmonary hypertension with IMATINIB
0.3%
of all IMATINIB reports
10
Deaths
29
Hospitalizations
How Dangerous Is Pulmonary hypertension From IMATINIB?
Of the 107 reports, 10 (9.3%) resulted in death, 29 (27.1%) required hospitalization, and 4 (3.7%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
Yes, Pulmonary hypertension is listed as a known adverse reaction in the official FDA drug label for IMATINIB.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which IMATINIB Alternatives Have Lower Pulmonary hypertension Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL